Big question, will the FDA ever approve Leronlimab with Nader Pourhassan as CytoDyn CEO?
So far the answer is no and judging by a recent FDA public statement, it looks even more unlikely than when the company received the RTF (Refusal To File) Letter from the FDA last year. Shareholders have not been able to learn for themselves what the RTF contained, as Pourhassan has stated at least three different reasons for FDA objections, but never released the actual contents of the letter during a CC or PR. That is very concerning. Make no mistake without FDA Approval Leronlimab is dead in the water and so is CytoDyn. It does not matter what Pourhassan says, and he has told many stories and made many statements, always with the caveat "hopefully" which I suppose is a CYA strategy to protect his being legally accountable.
I just want Leronlimab to have a shot at Approval. If that happens we're gold. Do I think Dr. Patterson would increase the odds of that happening? Absolutely, so he has my vote. As for the rest of the slate, while not perfect, they are far more qualified than the current Board, especially Melissa Yeager and Paul Rosenbaum.
BTW, the company has not released who their nominees will be because I suspect the two truly independent Directors. either won't be asked or will refuse to run because of the liabilities associated with recent litigation and the atmosphere created by the CEO. I don't think Pourhassan appreciated them forcing him to give back a significant percentage of his ill gotten stock booty and he may drop them from the Proxy Ticket.
